Capital Wealth Planning LLC Raises Holdings in Colgate-Palmolive (NYSE:CL)

Capital Wealth Planning LLC increased its position in Colgate-Palmolive (NYSE:CL) by 80.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 3,607 shares of the company’s stock after buying an additional 1,612 shares during the quarter. Capital Wealth Planning LLC’s holdings in Colgate-Palmolive were worth $328,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also made changes to their positions in CL. Swedbank AB raised its position in shares of Colgate-Palmolive by 1.4% in the 3rd quarter. Swedbank AB now owns 2,950,059 shares of the company’s stock worth $306,246,000 after buying an additional 40,324 shares during the period. Reston Wealth Management LLC purchased a new position in Colgate-Palmolive in the third quarter valued at about $42,000. Stephens Inc. AR raised its position in Colgate-Palmolive by 2.1% in the third quarter. Stephens Inc. AR now owns 11,951 shares of the company’s stock valued at $1,241,000 after purchasing an additional 251 shares during the period. Creative Financial Designs Inc. ADV raised its position in Colgate-Palmolive by 142.1% in the third quarter. Creative Financial Designs Inc. ADV now owns 869 shares of the company’s stock valued at $90,000 after purchasing an additional 510 shares during the period. Finally, Gladstone Institutional Advisory LLC raised its position in Colgate-Palmolive by 10.3% in the third quarter. Gladstone Institutional Advisory LLC now owns 6,758 shares of the company’s stock valued at $702,000 after purchasing an additional 631 shares during the period. 80.41% of the stock is owned by hedge funds and other institutional investors.

Colgate-Palmolive Stock Up 1.2 %

NYSE:CL opened at $91.27 on Friday. The company has a market capitalization of $74.07 billion, a price-to-earnings ratio of 25.93, a price-to-earnings-growth ratio of 4.20 and a beta of 0.44. Colgate-Palmolive has a one year low of $85.32 and a one year high of $109.30. The stock has a 50-day simple moving average of $88.74 and a 200 day simple moving average of $95.48. The company has a debt-to-equity ratio of 13.40, a quick ratio of 0.58 and a current ratio of 0.92.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, January 31st. The company reported $0.91 EPS for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period in the prior year, the business earned $0.87 earnings per share. Sell-side analysts predict that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st were paid a $0.50 dividend. The ex-dividend date of this dividend was Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a yield of 2.19%. Colgate-Palmolive’s payout ratio is currently 56.82%.

Wall Street Analysts Forecast Growth

CL has been the topic of several research reports. Royal Bank of Canada reissued a “sector perform” rating and issued a $101.00 price objective on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. Morgan Stanley cut their price objective on Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating on the stock in a research report on Monday, February 3rd. Stifel Nicolaus cut their price objective on Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating on the stock in a research report on Monday, February 3rd. Raymond James reissued an “outperform” rating and issued a $105.00 price objective (down from $110.00) on shares of Colgate-Palmolive in a research report on Monday, February 3rd. Finally, StockNews.com lowered Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating and eleven have given a buy rating to the company’s stock. According to data from MarketBeat, Colgate-Palmolive currently has an average rating of “Hold” and an average price target of $101.61.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.